204 related articles for article (PubMed ID: 34867853)
1. Foot-and-Mouth Disease Virus 3C Protease Antagonizes Interferon Signaling and C142T Substitution Attenuates the FMD Virus.
Ekanayaka P; Shin SH; Weeratunga P; Lee H; Kim TH; Chathuranga K; Subasinghe A; Park JH; Lee JS
Front Microbiol; 2021; 12():737031. PubMed ID: 34867853
[TBL] [Abstract][Full Text] [Related]
2. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation.
Du Y; Bi J; Liu J; Liu X; Wu X; Jiang P; Yoo D; Zhang Y; Wu J; Wan R; Zhao X; Guo L; Sun W; Cong X; Chen L; Wang J
J Virol; 2014 May; 88(9):4908-20. PubMed ID: 24554650
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
[TBL] [Abstract][Full Text] [Related]
4. Foot-and-Mouth Disease Virus 3C
Ekanayaka P; Weerawardhana A; Chathuranga K; Park JH; Lee JS
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146866
[TBL] [Abstract][Full Text] [Related]
5. Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5.
Kim H; Kim AY; Choi J; Park SY; Park SH; Kim JS; Lee SI; Park JH; Park CK; Ko YJ
Cells; 2021 Jan; 10(2):. PubMed ID: 33572945
[TBL] [Abstract][Full Text] [Related]
6. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling.
Wang D; Fang L; Li K; Zhong H; Fan J; Ouyang C; Zhang H; Duan E; Luo R; Zhang Z; Liu X; Chen H; Xiao S
J Virol; 2012 Sep; 86(17):9311-22. PubMed ID: 22718831
[TBL] [Abstract][Full Text] [Related]
7. Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway
Weerawardhana A; Uddin MB; Choi JH; Pathinayake P; Shin SH; Chathuranga K; Park JH; Lee JS
Front Immunol; 2022; 13():1020262. PubMed ID: 36248821
[TBL] [Abstract][Full Text] [Related]
8. Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression.
Liu H; Zhu Z; Xue Q; Yang F; Cao W; Zhang K; Liu X; Zheng H
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894473
[TBL] [Abstract][Full Text] [Related]
9. Potent small molecule inhibitors against the 3C protease of foot-and-mouth disease virus.
Kim Y; Pool E; Kim E; Dampalla CS; Nguyen HN; Johnson DK; Lovell S; Groutas WC; Chang K-O
Microbiol Spectr; 2024 Apr; 12(4):e0337223. PubMed ID: 38466127
[TBL] [Abstract][Full Text] [Related]
10. Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.
Puckette M; Clark BA; Smith JD; Turecek T; Martel E; Gabbert L; Pisano M; Hurtle W; Pacheco JM; Barrera J; Neilan JG; Rasmussen M
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878081
[TBL] [Abstract][Full Text] [Related]
11. Foot-and-Mouth Disease Virus Viroporin 2B Antagonizes RIG-I-Mediated Antiviral Effects by Inhibition of Its Protein Expression.
Zhu Z; Wang G; Yang F; Cao W; Mao R; Du X; Zhang X; Li C; Li D; Zhang K; Shu H; Liu X; Zheng H
J Virol; 2016 Dec; 90(24):11106-11121. PubMed ID: 27707918
[TBL] [Abstract][Full Text] [Related]
12. Foot-and-Mouth Disease Virus Induces Porcine Gasdermin E-Mediated Pyroptosis through the Protease Activity of 3C
Ren X; Yin M; Zhao Q; Zheng Z; Wang H; Lu Z; Li X; Qian P
J Virol; 2023 Jul; 97(7):e0068623. PubMed ID: 37367489
[TBL] [Abstract][Full Text] [Related]
13. Multiple-Site SUMOylation of FMDV 3C Protease and Its Negative Role in Viral Replication.
Wu X; Hu Y; Sui C; Pan L; Yoo D; Miller LC; Lee C; Cong X; Li J; Du Y; Qi J
J Virol; 2022 Sep; 96(17):e0061222. PubMed ID: 36005757
[TBL] [Abstract][Full Text] [Related]
14. 3C
Wu X; Chen L; Sui C; Hu Y; Jiang D; Yang F; Miller LC; Li J; Cong X; Hrabchenko N; Lee C; Du Y; Qi J
Virol Sin; 2023 Jun; 38(3):387-397. PubMed ID: 36921803
[TBL] [Abstract][Full Text] [Related]
15. Low levels of foot-and-mouth disease virus 3C protease expression are required to achieve optimal capsid protein expression and processing in mammalian cells.
Polacek C; Gullberg M; Li J; Belsham GJ
J Gen Virol; 2013 Jun; 94(Pt 6):1249-1258. PubMed ID: 23364188
[TBL] [Abstract][Full Text] [Related]
16. Production of foot-and-mouth disease virus capsid proteins by the TEV protease.
Puckette M; Smith JD; Gabbert L; Schutta C; Barrera J; Clark BA; Neilan JG; Rasmussen M
J Biotechnol; 2018 Jun; 275():7-12. PubMed ID: 29581033
[TBL] [Abstract][Full Text] [Related]
17. Andrographolide and Deoxyandrographolide Inhibit Protease and IFN-Antagonist Activities of Foot-and-Mouth Disease Virus 3C
Theerawatanasirikul S; Lueangaramkul V; Thangthamniyom N; Chankeeree P; Semkum P; Lekcharoensuk P
Animals (Basel); 2022 Aug; 12(15):. PubMed ID: 35953984
[TBL] [Abstract][Full Text] [Related]
18. Degradation of Host Proteins and Apoptosis Induced by Foot-and-Mouth Disease Virus 3C Protease.
Yi J; Peng J; Ren J; Zhu G; Ru Y; Tian H; Li D; Zheng H
Pathogens; 2021 Nov; 10(12):. PubMed ID: 34959521
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
[TBL] [Abstract][Full Text] [Related]
20. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD.
Qu L; Feng Z; Yamane D; Liang Y; Lanford RE; Li K; Lemon SM
PLoS Pathog; 2011 Sep; 7(9):e1002169. PubMed ID: 21931545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
